Previously Alex held the role of Vice president of Regional Growth Initiatives and was business leader for Greater China Minimally Invasive Therapies Group (MITG). He joined Medtronic in 2015 upon the close of the Covidien acquisition. At Covidien, he was President of China region and had overseen all the businesses and functions since 2009.
Before Covidien, Alex was in various leadership positions at McKinsey & Company, General Electric, and Sabic, both in the United States and China. He started his career as a member of the GE Edison Leadership Program (ELP), then served several roles with increasing responsibilities within GE Healthcare in the U.S.
As one of AdvaMed China Council's founding members, Alex was elected Chairman of the AdvaMed China Board in January 2023. He holds the role of Independent Non-Executive Director of a Hong Kong-listed pharmaceutical company.
Alex's contributions to healthcare industry earned him the prestigious Shanghai Magnolia Award in 2021. The 14th Health China Forum named him one of the Top 10 Healthcare Leaders in 2022.
Alex holds an MBA from the University of Chicago's Booth School of Business. He is a Fellow of the Aspen Institute China Fellowship Program and a member of the Aspen Global Leadership Network.